Pharma firm AstraZeneca which is partnering the university admitted the mistake following US reports that its best dosage only worked well in younger people.
Full ArticleVaccine blow as Oxford Covid-19 trial to be re-run after research error
Daily Record
0 shares
1 views
You might like
Related news coverage
Volunteer seeks investigation on Serum after developing complication but company is intimidating
Mid-Day
The 40-year old volunteer, who works as a business consultant had wanted to investigate the cause of him contracting severe..
-
Serum Institute files Rs 100 crore defamation case after man says vaccine left him ill
Mid-Day
-
Man who undertook Covidshield vaccine trial alleges neurological breakdown, seeks Rs 5 crore compensation
Mid-Day
-
AstraZeneca-Oxford vaccine: Trial error leaves doubt about authorizing emergency use
DNA
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
Advertisement
More coverage
Oxford/AstraZeneca Covid vaccine 'dose error' explained
BBC News
Some trial volunteers were given shots half the planned strength, so how does that affect the results?